Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tildrakizumab in moderate-to-severe chronic plaque psoriasis
NCT01936688Phase 3Withdrawn
- Sponsor
- Sun Pharma
- Start
- Sep 2013
- Primary completion
- Aug 2018
01
Overview
A Phase 3 trial of tildrakizumab in plaque psoriasis, sponsored by Sun Pharma. Planned start Sep 2013; status: withdrawn.
02
Drugs
tildrakizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01936688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936688.